Evidence map›Paper›PMID 39811702›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Identifying cognitive test scores associated with early tau burden in Alzheimer's disease.

Caitlin M Terao, Madeline Wood Alexander, R Philip Chalmers, Silina Z Boshmaf, Jane Paterson, Sandra E Black, Kathryn V Papp, Reisa A Sperling, Jennifer S Rabin

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. A multiverse analysis of the logical memory test and plasma biomarkers of Alzheimer's disease.Cortex; a journal devoted to the study of the nervous system and behavior · 2026
    Article
  2. Article
  3. Disease stage-specific atrophy markers in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Caitlin M TeraoHurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.ORCID https://orcid.org/0000-0002-5506-9625
Madeline Wood AlexanderHurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.
R Philip ChalmersDepartment of Psychology, York University Toronto Ontario Canada.
Silina Z BoshmafHurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.
Jane PatersonHurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.
Sandra E BlackHurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.
Kathryn V PappCenter for Alzheimer Research and Treatment Department of Neurology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
Reisa A SperlingCenter for Alzheimer Research and Treatment Department of Neurology Brigham and Women's Hospital Harvard Medical School Boston Massachusetts USA.
Jennifer S RabinHurvitz Brain Sciences Program Sunnybrook Research Institute Toronto Ontario Canada.

Funding

The Alzheimer's Clinical Trial Consortium - Down Syndrome Network (ACTC- DSN)U24AG057437 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Paul S. Aisen, RONALD C PETERSEN · 2018 to 2026
$198.4M
RECRUITMENT COREU19AG010483 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDMAN, HOWARD · 2013 to 2020
$80.6M
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Rebecca E Amariglio · 2010 to 2026
$50.2M
Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension StudyR01AG063689 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI AISEN, PAUL S., SPERLING, REISA A. · 2019 to 2024
$30.8M
NIA NIH HHS P01 AG036694NIA NIH HHS R01 AG063689NIA NIH HHS U19 AG010483NIA NIH HHS U24 AG057437
6 · The paper itself

Abstract

introductionThis study aimed to identify cognitive tests that optimally relate to tau positron emission tomography (PET) signal in the inferior temporal cortex (ITC), a neocortical region associated with early tau accumulation in Alzheimer's disease (AD).

methodsWe analyzed cross-sectional data from the harvard aging brain study (HABS) (

resultsEpisodic memory measures, including both total and "process" scores, were the most robust correlates of ITC tau across both cohorts. These cognitive test scores remained significant after accounting for structural brain measures. DISCUSSION: These findings highlight the potential of specific episodic memory test scores to detect and monitor neuropathological changes associated with early AD. Highlights: Machine learning identified cognitive correlates of early Alzheimer's disease tau burden.Both traditional and process scores predicted early tau burden.Episodic memory scores were among the strongest correlates.Cognitive scores remained significant after accounting for structural brain measures.

Indexed as

Alzheimer's pathologyelastic net regressionmachine learningneuropsychologytau PET

Identifiers

PMID39811702
PMCPMC11730071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.